Supportive medications and interventions received by prostate cancer survivors: results from the PiCTure study

Supportive medications and interventions received by prostate cancer survivors: results from the PiCTure study
复制标题

前列腺癌幸存者接受的支持性药物和干预措施:PiCture 研究的结果

DOI:
10.12788/jcso.0384
复制
发表时间:
2017
期刊:
The Journal of community and supportive oncology
影响因子:
--
通讯作者:
L. Sharp
L. Sharp
中科院分区:
--
文献类型:
--
作者:
F. Drummond;A. Gavin;L. Sharp

文献摘要

被引文献

相似文献

前列腺癌的治疗与各种生理后遗症有关,包括泌尿系症状、性症状和肠道症状。1术后可对幸存者的健康相关生活质量产生影响。2已有药物和外科干预措施可用于管理或改善许多这些后遗症(例如,放疗期间和放疗后服用西地那和L柠檬酸盐可改善性功能),3并且接受治疗对患者的性功能有积极影响。4然而,临床医生的研究表明,此类干预措施可能不会被广泛使用。5,6缺乏关于这一主题的报道数据。因此,在这项以人群为基础的前列腺癌幸存者研究中,我们调查了支持性药物和干预措施的使用。方法前列腺癌治疗,您的经验)研究方法已在其他地方描述。7 Brieéy,6,559名前列腺癌幸存者(诊断于1995年1月1日至2010年3月31日期间确诊,2011年11月仍活着),从爱尔兰共和国和北爱尔兰的基于人口的癌症登记中获得身份,被邀请完成一项邮寄调查。寻求有关治疗后任何时候经历过的后遗症(大小便失禁、阳萎、女性乳房发育、潮热、出汗、肠道问题、抑郁)的信息。每次检查后,男性都会被问到他们是否接受过任何缓解症状的药物或干预措施,如果是,他们接受了什么;常见干预的例子是-
Prostate cancer treatments are associated with various physical after-e ects, including urinary, sexual, and bowel symptoms.1 ese after-e ects can have an impact on survivors’ healthrelated quality of life (HRQoL).2 Pharmaceutical and surgical interventions are available to manage or ameliorate many of these after-e ects (eg, sildena…l citrate taken during and after radiotherapy improves sexual function),3 and their receipt has a positive impact on HRQoL.4 However, studies of clinicians suggest that such interventions may not be used widely.5,6 Patientreported data on this topic is lacking. erefore, we investigated the use of supportive medications and interventions in this population-based study of prostate cancer survivors. Methods e PiCTure (Prostate Cancer Treatment, Your Experience) study methods have been described elsewhere.7 BrieŽy, 6,559 prostate cancer survivors 2-15 years after diagnosis (diagnosed during January 1, 1995-March 31, 2010, and alive in November 2011), identi…ed from population-based cancer registries in the Republic of Ireland and Northern Ireland, were invited to complete a postal survey. Information was sought on after-e ects (incontinence, impotence, gynaecomastia, hot Žashes/sweats, bowel problems, depression) that had been experienced at any time after treatment. For each after-e ect, men were asked if they had received any medication or interventions to alleviate symptoms, and, if so, what they had received; examples of common interven-